SEC Tracker
Get the app

INSMED INSM

Paul Hudson (Director) was awarded 6,139 INSM

Form
4
Filed
Importance
Routine
  1. Hudson Paul received 6,139 shares of common stock
  2. The shares were granted as restricted stock units (RSUs)
  3. RSUs vest over three years
  4. No consideration was paid for the RSUs

Written from the Form 4 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when INSMED files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Biogen BIIB public float $18.4B, Jun 30, 2025
  2. Teva Pharmaceutical Industries TEVA public float $18.2B, Jun 30, 2025
  3. BeOne Medicines ONC public float $14.7B, Jun 30, 2025
  4. United Therapeutics UTHR public float $11.2B, Jun 30, 2025
  5. Alnylam Pharmaceuticals ALNY public float $42.6B, Jun 30, 2025